drug
OSE-2101
Phase 3updated 5mo agoby OSE Immunotherapeutics SA
Phase 3community read0 votes
indications
indications
NSCLC
all catalysts(0)
nothing on the calendar yet
News(1)
- 5 drugmakers chasing Merck and Moderna in the cancer vaccine raceFollowing their blowout win in melanoma last month, Merck and Moderna are leading the way among a new crop of personalized cancer vaccines. Here are five companies with similar therapies hoping to…biospace · 19d ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that